Zenith Epigenetics

And judging by what RVX went through to get to a Phase III, let's not delude ourselves into believing that things will be any different here when we are at the early stage of a Phase I Clinical Studies in Matastatics CRPC with ZEN-3694. Unfortunately, we cannot wave a magic wand and bingo. We are still in the infant stage are we not?

Hopfully this time things will go better from lessons learned from RVX-208. ( IMO )

Koo